Fny Investment Advisers, LLC Mersana Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$1.06 - $3.91 $1,166 - $4,301	1,100 New	1,100 $1,000
Q1 2021 Apr 12, 2021	SELL	$15.31 - $26.52 $2.53 Million - $4.38 Million	-165,200 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$16.84 - $27.59 $582,664 - $954,614	-34,600 Reduced 17.32%	165,200 $4.4 Million
Q3 2020 Oct 09, 2020	BUY	$16.2 - $25.7 $897,139 - $1.42 Million	55,379 Added 38.35%	199,800 $3.72 Million
Q2 2020 Jul 10, 2020	BUY	$5.24 - $23.4 $450,750 - $2.01 Million	86,021 Added 147.3%	144,421 $3.38 Million
Q1 2020 Apr 09, 2020	BUY	$4.41 - $9.28 $257,544 - $541,952	58,400 New	58,400 $340,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.